RATIONAL IMMUNOTHERAPY WITH INTERLEUKIN-2

被引:40
作者
KAPLAN, G [1 ]
COHN, ZA [1 ]
SMITH, KA [1 ]
机构
[1] DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT MED,HANOVER,NH 03756
来源
BIO-TECHNOLOGY | 1992年 / 10卷 / 02期
关键词
D O I
10.1038/nbt0292-157
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interleukin 2 (IL-2), a T lymphocyte product released upon antigen stimulation, has been used for cancer therapy in high doses for more than five years. More recently, its potential as a stimulant of cell-mediated immunitY in infectious diseases, particularly those caused by intracellular microbes, has become appreciated. Drawing on the extensive information available as to the structure, cellular and molecular effects of IL-2, this review focuses on its use in patients with lepromatous leprosy and AIDS in low, physiologic doses. The data indicate that IL-2 is effective in stimulating cell-mediated immunity without systemic toxicity.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 44 条
[31]   SEQUENTIAL EXPRESSION OF PROTOONCOGENES DURING LECTIN-STIMULATED MITOGENESIS OF NORMAL HUMAN-LYMPHOCYTES [J].
REED, JC ;
ALPERS, JD ;
NOWELL, PC ;
HOOVER, RG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) :3982-3986
[32]   CHARACTERIZATION OF FUNCTIONAL SURFACE-STRUCTURES ON HUMAN NATURAL-KILLER CELLS [J].
RITZ, J ;
SCHMIDT, RE ;
MICHON, J ;
HERCEND, T ;
SCHLOSSMAN, SF .
ADVANCES IN IMMUNOLOGY, 1988, 42 :181-211
[33]   T-CELL GROWTH-FACTOR RECEPTORS - QUANTITATION, SPECIFICITY, AND BIOLOGICAL RELEVANCE [J].
ROBB, RJ ;
MUNCK, A ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (05) :1455-1474
[34]  
SALTZMAN EM, 1990, J BIOL CHEM, V265, P10138
[35]  
SALTZMAN EM, 1988, J BIOL CHEM, V263, P6956
[36]   THALIDOMIDE SELECTIVELY INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY STIMULATED HUMAN MONOCYTES [J].
SAMPAIO, EP ;
SARNO, EN ;
GALILLY, R ;
COHN, ZA ;
KAPLAN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :699-703
[37]   DEVELOPMENT AND FUNCTION OF T-CELLS IN MICE RENDERED INTERLEUKIN-2 DEFICIENT BY GENE TARGETING [J].
SCHORLE, H ;
HOLTSCHKE, T ;
HUNIG, T ;
SCHIMPL, A ;
HORAK, I .
NATURE, 1991, 352 (6336) :621-624
[38]  
SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397
[39]   INTERLEUKIN-2 - INCEPTION, IMPACT, AND IMPLICATIONS [J].
SMITH, KA .
SCIENCE, 1988, 240 (4856) :1169-1176
[40]  
STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754